|
SLFN5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6531999999958E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.520060E-03 |
| Normal-vs-Stage2 |
4.388200E-02 |
| Normal-vs-Stage3 |
1.940280E-02 |
| Normal-vs-Stage4 |
1.395200E-01 |
| Stage1-vs-Stage2 |
4.485200E-01 |
| Stage1-vs-Stage3 |
2.527600E-01 |
| Stage1-vs-Stage4 |
6.189800E-01 |
| Stage2-vs-Stage3 |
8.521600E-01 |
| Stage2-vs-Stage4 |
9.538800E-01 |
| Stage3-vs-Stage4 |
8.381000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.93950000000021E-05 |
| Normal-vs-AfricanAmerican |
4.302700E-03 |
| Normal-vs-Asian |
5.291200E-01 |
| Caucasian-vs-AfricanAmerican |
9.244000E-01 |
| Caucasian-vs-Asian |
4.714800E-01 |
| AfricanAmerican-vs-Asian |
4.471800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.581700E-04 |
| Normal-vs-Female |
1.79242999999163E-05 |
| Male-vs-Female |
7.044700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.151800E-02 |
| Normal-vs-Extreme_Weight |
8.730400E-02 |
| Normal-vs-Obese |
5.85399999999403E-05 |
| Normal-vs-Extreme_Obese |
5.010600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.429800E-01 |
| Normal_Weight-vs-Obese |
9.163800E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.652600E-01 |
| Extreme_Weight-vs-Obese |
2.699600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.518000E-01 |
| Obese-vs-Extreme_Obese |
1.612570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.935680E-02 |
| Normal-vs-Age(41-60Yrs) |
3.25530000000462E-06 |
| Normal-vs-Age(61-80Yrs) |
6.402000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.745400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.105000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.769600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.287970E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.688280E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.565600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.495600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.982500E-04 |
| Normal-VS-Type2 PRCC |
6.106200E-02 |
| Normal-VS-KIRP CIMP |
1.963140E-03 |
| Normal-VS-Unclassified PRCC |
5.226200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.656800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.760500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.706200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.044900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.385680E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.441700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.963800E-02 |
| Normal-vs-N1 |
5.379400E-03 |
| Normal-vs-N2 |
3.999600E-01 |
| N0-vs-N1 |
4.994000E-02 |
| N0-vs-N2 |
6.529600E-01 |
| N1-vs-N2 |
5.631000E-01 |
|
|
